trending Market Intelligence /marketintelligence/en/news-insights/trending/cd7npsa93nmskdlnwqaplg2 content esgSubNav
In This List

Sonoma Pharmaceuticals prices $5M common stock offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Sonoma Pharmaceuticals prices $5M common stock offering

Sonoma Pharmaceuticals Inc. is selling 1,428,571 common shares at $3.50 apiece to raise about $5 million of gross proceeds in a "best efforts" public offering.

Closing is expected to occur March 6, subject to customary closing conditions.

Dawson James Securities Inc. is acting as the lead placement agent and sole book runner in the offering, with Benchmark Co. LLC as co-placement agent.

Sonoma Pharmaceuticals is a Petaluma, Calif.-based specialty pharmaceutical company that develops and sells treatments for dermatological conditions and advanced tissue care.